Tom Crosby
Overview
Explore the profile of Tom Crosby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holland-Hart D, Longo M, Bridges S, Nixon L, Hawkins M, Crosby T, et al.
Trials
. 2025 Feb;
26(1):70.
PMID: 40012034
Introduction: This qualitative study explored patients' experiences and perceptions of the SCOPE2 trial. The trial studied radiotherapy dose escalation in patients with inoperable oesophageal cancer treated with definitive chemo-radiation. SCOPE2...
2.
Crosby B, Munglani L, Wright K, Charles K, Evans W, Mathias M, et al.
BMJ Open Qual
. 2025 Jan;
14(1).
PMID: 39884722
Introduction: Demand for endoscopic services is outstripping capacity in the UK. Transnasal endoscopy (TNE) utilises a narrow calibre endoscope to pass through the nasal passages, thereby reducing retching and discomfort....
3.
Palmer D, Jackson R, Springfeld C, Ghaneh P, Rawcliffe C, Halloran C, et al.
J Clin Oncol
. 2024 Dec;
:JCO2401118.
PMID: 39637340
Purpose: The ESPAC4 trial showed that adjuvant chemotherapy with gemcitabine plus capecitabine (GemCap) produced longer overall survival (OS) than gemcitabine monotherapy. Subsequently, the PRODIGE24-CCTG PA.6 trial showed even longer survival...
4.
Holland-Hart D, Longo M, Bridges S, Nixon L, Hawkins M, Crosby T, et al.
BMJ Open
. 2024 Sep;
14(9):e076394.
PMID: 39313288
Objectives: This qualitative study explored patients' experiences and perceptions of the SCOPE2 trial. SCOPE2 examined radiotherapy dose escalation in patients with inoperable oesophageal cancer treated with definitive chemoradiotherapy (dCRT). Setting:...
5.
Pucher P, Rahman S, Bhandari P, Blencowe N, Chidambaram S, Crosby T, et al.
Ann Surg
. 2024 Sep;
281(3):363-370.
PMID: 39219545
Objective: The aim of this study was to quantify lymph node metastasis (LNM) risk and outcomes following treatment of early esophago-gastric (EG) adenocarcinoma. Background: The standard of care for early...
6.
di Pietro M, Trudgill N, Vasileiou M, Longcroft-Wheaton G, Phillips A, Gossage J, et al.
Gut
. 2024 Mar;
73(6):897-909.
PMID: 38553042
Barrett's oesophagus is the only known precursor to oesophageal adenocarcinoma, a cancer with very poor prognosis. The main risk factors for Barrett's oesophagus are a history of gastro-oesophageal acid reflux...
7.
Gunn C, Crosby T, Nanton A, Gorvin L
Alcohol
. 2024 Feb;
121:95-102.
PMID: 38423260
Recently, researchers have proposed an updated model of executive functions that includes relational integration, the mental ability to bind information into more complex structures. Hangover is known to disrupt other...
8.
Markar S, Guazzelli A, Taylor A, Jones L, Dutton S, Jogarah V, et al.
Br J Surg
. 2023 Jun;
110(10):1359-1360.
PMID: 37376769
No abstract available.
9.
England T, Harper P, Crosby T, Gartner D, Arruda E, Foley K, et al.
J Simul
. 2023 Feb;
17(1):94-104.
PMID: 36760877
The United Kingdom has one of the poorest lung cancer survival rates in Europe. In this study, to help design and evaluate a single lung cancer pathway (SCP) for Wales,...
10.
Nilsson M, Olafsdottir H, Alexandersson von Dobeln G, Villegas F, Gagliardi G, Hellstrom M, et al.
Front Oncol
. 2022 Aug;
12:917961.
PMID: 35912196
Background: The globally dominant treatment with curative intent for locally advanced esophageal squamous cell carcinoma (ESCC) is neoadjuvant chemoradiotherapy (nCRT) with subsequent esophagectomy. This multimodal treatment leads to around 60%...